Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,506
Closed -$419K 770
2023
Q1
$419K Sell
8,506
-7,922
-48% -$459K ﹤0.01% 811
2022
Q4
$879K Sell
16,428
-3,239
-16% -$167K 0.01% 723
2022
Q3
$906K Buy
+19,667
New +$1.07M 0.01% 728

Other funds holding ENOV

Candriam SCA's ENOV Position: Q2 2023 in Review

Candriam SCA sold out of Enovis (ENOV) in Q2 2023, closing a stake of 8,506 shares — an estimated $419K sold.

Candriam SCA first reported a position in ENOV in Q3 2022 and held it in 3 quarters. The position peaked at $906K in Q3 2022. 261 funds tracked by Wall St. Rank hold ENOV as of Q2 2023.

  • Candriam SCA reported no remaining Enovis position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 8,506 Enovis shares in Q2 2023, an estimated $419K.
  • Candriam SCA first reported a position in Enovis in Q3 2022 and held it in 3 quarters.
  • Candriam SCA's Enovis position peaked at $906K in Q3 2022.
  • 261 funds tracked by Wall St. Rank held Enovis as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.